Our gene expression assay capabilities empower researchers and biopharma partners to uncover critical insights into disease mechanisms, therapeutic response, and biomarker discovery. With advanced technologies and deep scientific expertise, we deliver high-quality, regulatory-ready data to support your clinical development programs.
Our gene expression assays are designed to meet the evolving needs of modern clinical research, with applications across oncology, immunology, infectious disease, and gene therapy. We offer:
Quantitative PCR (qPCR/ddPCR) for precise gene expression quantification, viral load monitoring, and biodistribution analysis
Next-Generation Sequencing (NGS) and Sanger Sequencing for whole exome, RNA sequencing, and viral genotyping
Nanostring Technology for high-performance digital gene expression and immune profiling
PanCancerIQ™ NGS Genomic Profiling for comprehensive cancer biomarker analysis
Multi-omic Biomarker Integration to provide a holistic view of biological systems
Our assays are validated under CAP/CLIA standards and supported by robust bioinformatics expertise, ensuring accurate interpretation and actionable insights.
Predictive Biomarker Discovery
Immune Response Monitoring
Therapeutic Efficacy Assessment
Tumor Microenvironment Analysis
Gene Therapy Safety & Efficacy Evaluation
Viral Vector Shedding & Biodistribution Studies